Phase I and II trial on infusional 5-fluorouracil and gefitinib in combination with preoperative radiotherapy in rectal cancer: 10-years median follow-up
Tóm tắt
Từ khóa
Tài liệu tham khảo
Van de Valde, 2014, EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum, Eur J Cancer, 50, 1.e1, 10.1016/j.ejca.2013.06.048
Rodel, 2015, Oxaliplatin added to fluorouracil-based preoperative chemotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomized, phase 3 trial, Lancet Oncol, 16, 979, 10.1016/S1470-2045(15)00159-X
Glimelius, 2013, Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, 24, 81, 10.1093/annonc/mdt240
Crane, 2002, Preoperative chemoradiation for locally advanced rectal cancer: emerging treatment strategies, Oncology (Williston Park), 16, 39
Gerard, 2010, Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the Phase III Trial ACCORD 12/0405-Prodige 2, J Clin Oncol, 28, 1638, 10.1200/JCO.2009.25.8376
Valentini, 2004, Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: Phase I and II studies, Int J Radiat Oncol Biol Phys, 60, 139, 10.1016/j.ijrobp.2004.01.051
Aschele, 2011, Primary tumor response to preoperative Chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic Results of the STAR-01 Randomized Phase III trial, J Clin Oncol, 29, 2773, 10.1200/JCO.2010.34.4911
Valentini, 2008, Infusional 5-fluorouracil and ZD1839 (gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II trial Int, J Radiat Oncol Biol Phys, 72, 644, 10.1016/j.ijrobp.2008.01.046
Capirci, 2011, Dislocation of small bowel volume within box pelvic treatment fields, using new “up down table” device, Int J Radiat Oncol Biol Phys, 51, 465, 10.1016/S0360-3016(01)01644-3
De Gramont, 1997, Randomized trial comparing monthly low-dose leucovorin and flourouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study, J Clin Oncol, 15, 808, 10.1200/JCO.1997.15.2.808
Mandard, 1994, Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: clinicopathologic correlation, Cancer, 73, 2680, 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C
U.S. Department of Health and Human Services -National Cancer Institute: Common Terminology Criteria for Adverse Events (CTCAE) 2010; Version 4.03:68.
International Commission on Radiation Units and Measurements. ICRU Report 50: Prescribing, recording and reporting photon beam therapy; 1993.
International Commission on Radiation Units and Measurement ICRU Report 62: Prescribing, recording photon beam therapy (supplement to ICRU Report 50); 1999.
Sauer, 2012, Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years, J Clin Oncol, 30, 1926, 10.1200/JCO.2011.40.1836
Lopez-Gomez, 2012, Long-term treatment of metastatic colorectal cancer with panitumumab, Clin Med insights Oncol, 6, 125, 10.4137/CMO.S5055
Cohen, 2013, Approval summary: cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil for the first line treatment of patients with recurrent loco-regional or metastatic squamous cell head and neck cancer, Oncologist, 18, 460, 10.1634/theoncologist.2012-0458
Dewdney, 2012, Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C), J Clin Oncol, 30, 1620, 10.1200/JCO.2011.39.6036
Kripp, 2015, Does the addition of cetuximab to radiochemotherapy improve outcome of patients with locally advanced rectal cancer? long-term results from phase II trials, Gastroenterol Res Pract, 2015, 273489, 10.1155/2015/273489
Rodel, 2008, Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer, Int J Radiat Oncol Biol Phys, 70, 1081, 10.1016/j.ijrobp.2007.07.2356
Richter, 2015, The prognostic significance of tumor epidermal growth factor re- ceptor (EGFR) expression change after neoadjuvant chemoradiation in patients with rectal adenocarcinoma, Contemp Oncol, 19, 48
Czito, 2006, Increased toxicity with gefitinib, capacitabine, and radiation therapy in pancreatic and rectal cancer: Phase I trial results, J Clin Oncol, 24, 656, 10.1200/JCO.2005.04.1749
Palumbo, 2014, Gefitinib enhances the effects of combined radiotherapy and 5-fluorouracil in a colorectal cancer cell line, Int J Colorectal Dis, 29, 31, 10.1007/s00384-013-1754-1
Peeters, 2005, Late side effects of short-course preoperative radiotherapy combined with total mesolectal excision for rectal cancer:increased bowel-disfuntion in irradiated patients-a Dutch colorectal cancer group study, J Clin Oncol, 23, 6199, 10.1200/JCO.2005.14.779
Marijnen, 2005, Impact of short-therm preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multi center randomized trial, J Clin Oncol, 23, 1847, 10.1200/JCO.2005.05.256
Stephens, 2010, Impact of short-course preoperative radiotherapy for rectal cancer on patients quality of life: data from the medical research council CR/07/National Cancer Institute of Canada clinical trials group C016 randomized clinical trial, J Clin Oncol, 28, 4233, 10.1200/JCO.2009.26.5264
Coco, 2013, Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome, Surg Endosc, 27, 2860, 10.1007/s00464-013-2842-6